Value & AccessDiscovering new treatments is critical to improving patient outcomes; however, if these new treatments are not affordable or accessible, their outcomes may have minimal impact for patients and healthcare systems. DIA has helped introduce the integration of value and access discussions, in particular patient perspectives on health outcomes, earlier and more broadly throughout the product development process and lifecycle management.

Insights

Value and Access Toolkit: Download Now

Value and Access Toolkit

Solutions to affordability and patient access are constantly evolving. Stay tuned into the ongoing conversations between policymakers, payers, and HTA bodies. Download DIA’s Value and Access Toolkit to get access to DIA’s new interviews, exclusive video recordings, and articles featuring value and access content.

Download Toolkit

Regulatory Affairs Community

DIA Communities

Regulatory Affairs Professionals connect to share non-proprietary global information and best practices for new and emerging regulatory requirements in the development and commercialization of healthcare treatments. Working groups include CMC, Labeling, AdPromo, Regulatory Intelligence, and Regulatory Information Management.

Explore the Community
Featured Networking and Knowledge Exchange